요약정보
Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
- Resource Type
- Academic Journal
- Authors
- Labrosse R; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Immune Deficiency-Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Division of Allergy and Immunology, Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada.; Chu JI; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Division of Pediatric Allergy, Immunology and Bone Marrow Transplantation, Benioff Children's Hospital, University of California San Francisco, San Francisco, CA.; Armant MA; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Everett JK; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Pellin D; Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Kareddy N; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Frelinger AL; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Henderson LA; Division of Immunology, Boston Children's Hospital, Boston, MA.; O'Connell AE; Division of Newborn Medicine, Boston Children's Hospital, Boston, MA.; Biswas A; Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Coenen-van der Spek J; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Miggelbrink A; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Fiorini C; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Adhikari H; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Berry CC; Division of Biostatistics and Bioinformatics, Herbert Wertheim School of Public Health, UC San Diego, La Jolla, CA.; Cantu VA; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Fong J; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Jaroslavsky J; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Karadeniz DF; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Li QZ; Department of Immunology, Microarray and Immune Phenotyping Core Facility, University of Texas Southwestern Medical Center, Dallas, TX.; Reddy S; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Roche AM; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Zhu C; Department of Immunology, Microarray and Immune Phenotyping Core Facility, University of Texas Southwestern Medical Center, Dallas, TX.; Whangbo JS; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Dansereau C; Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Mackinnon B; Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Morris E; Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Koo SM; Gene Therapy Program, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; London WB; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Baris S; Department of Pediatrics, Division of Allergy and Immunology, Marmara University, Istanbul, Turkey.; The Işıl Berat Barlan Center for Translational Medicine, Marmara University, Istanbul, Turkey.; Ozen A; Department of Pediatrics, Division of Allergy and Immunology, Marmara University, Istanbul, Turkey.; The Işıl Berat Barlan Center for Translational Medicine, Marmara University, Istanbul, Turkey.; Karakoc-Aydiner E; Department of Pediatrics, Division of Allergy and Immunology, Marmara University, Istanbul, Turkey.; The Işıl Berat Barlan Center for Translational Medicine, Marmara University, Istanbul, Turkey.; Despotovic JM; Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX.; Forbes Satter LR; Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital, Houston, TX.; Saitoh A; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.; Aizawa Y; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.; King A; Hospital Luis Calvo Mackenna, Clínica Alemana De Santiago Universidad del Desarrollo, Santiago, Chile.; Nguyen MAT; Department of Pediatrics, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.; Vu VDU; Department of Pediatrics, University of Medicine and Pharmacy at Ho Chi Minh City, Ho Chi Minh City, Vietnam.; Snapper SB; Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Galy A; Genethon, Évry, France.; University of Paris-Saclay, University of Évry, INSERM, Genethon, Integrare Research Unit UMR_S951, Évry, France.; Notarangelo LD; Division of Immunology, Boston Children's Hospital, Boston, MA.; Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.; Bushman FD; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA.; Williams DA; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Pai SY; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.; Immune Deficiency-Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
- Source
- Publisher:
Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN:00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE - Subject
- Language
- English